id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S8483 R27811 |
Yoshihara (Controls exposed to PTU), 2021 | Omphalocele | 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
4.79 [0.22;102.66] C excluded (control group) |
0/23 2/541 | 2 | 23 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8482 R27789 |
Yoshihara (Controls unexposed, sick), 2021 | Omphalocele | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 2.99 [0.15;59.73] C | 0/23 3/475 | 3 | 23 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3353 R5980 |
Yoshihara (control exposed to PTU), 2012 | Omphalocele | 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
14.85 [0.84;263.84] C excluded (control group) |
6/1,231 0/1,399 | 6 | 1,231 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3350 R5843 |
Yoshihara (control unexposed, sick), 2012 | Omphalocele | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 20.23 [1.14;359.44] C | 6/1,231 0/1,906 | 6 | 1,231 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3379 R6253 |
Clementi, 2010 | Omphalocele | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes | 10.40 [2.90;37.26] | 6/80 148/18,051 | 154 | 80 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 9.70 [3.27;28.78] | 163 | 1,334 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick; 2: control unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 3353, 8483